期刊文献+

生境成像在肿瘤中的应用进展

Application advances of tumor habitat imaging
下载PDF
导出
摘要 生境成像作为一项以生物学环境为基础的影像组学技术,可通过定量影像学标志物聚类具有相似表征的肿瘤细胞群,从而显示和量化肿瘤内部异质性。生境成像可无创精准定位病灶、预测肿瘤分型及预后、表征肿瘤病理和分子特征、鉴别肿瘤进展与治疗反应等,在促进临床诊疗精准化方面表现出极大的潜能。就肿瘤生境成像的研究进展进行综述。 As a biological environment-based radiomics technology,habitat imaging can reveal and quantify intratumor heterogeneity through quantitative imaging biomarkers clustering tumor cell groups with similar phenotypes.Habitat imaging can non-invasively localize lesions,predict tumor staging and prognosis,characterize tumor pathology and molecular features,and identify tumor progression or treatment response,etc.Additionally,it has demonstrated great potential in promoting the accuracy of clinical diagnosis and treatment.The purpose of this article is to review the progress in tumor habitat imaging research.
作者 袁蕾 李延静 宦怡 任静(审校) YUAN Lei;LI Yanjing;HUAN Yi;REN Jing(Medical School of Yan’an University,Yan’an 716000,China;Department of Radiology,The First Affiliated Hospital,Air Force Medical University)
出处 《国际医学放射学杂志》 北大核心 2023年第6期721-724,共4页 International Journal of Medical Radiology
基金 陕西省自然科学基础研究重点项目(2021JZ-25)。
关键词 生境成像 磁共振成像 肿瘤内部异质性 肿瘤微环境 Habitat imaging Magnetic resonance imaging Intra-tumor heterogeneity Tumor microenvironment
  • 相关文献

参考文献2

二级参考文献110

  • 1Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
  • 2Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature 2013; 501: 328-37.
  • 3Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146: 633-44.
  • 4Marjanovic ND, Weinberg RA, Chaffer CL. Cell plasticity and heterogeneity in cancer. Clin Chem 2013; 59:168-79.
  • 5Cohen P, Alessi DR. Kinase drug discovery-what’s next in the field? ACS Chem Biol 2013; 8: 96-104.
  • 6Gonzalez de Castro D, Clarke PA, Al-Lazikani B, Workman P. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance. Clin Pharmacol Ther 2013; 93: 252-9.
  • 7Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013; 501: 338-45.
  • 8Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y, et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci U S A 2012; 109: 3041-6.
  • 9Little SE, Popov S, Jury A, Bax DA, Doey L, Al-Sarraj S, et al. Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity. Cancer Res 2012; 72:1614-20.
  • 10Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部